LEXICON THERAPEUTICS
Similar Organizations
BioSampleZone
BioSampleZone is a reseller of pharmaceutical samples.
Corino Therapeutics
Corino Therapeutics is a private, development-stage biopharmaceutical company
Genetic Immunity Inc
Genetic Immunity Inc is a company that manufactures vaccines.
INO Therapeutics
INO Therapeutics is a company that offers pharmaceuticals products.
PorA Pharmaceuticals
A private pharmaceutical company with an asset, amixicile, acquired from the University of Virginia.
SanoGene Therapeutics
SanoGene Therapeutics is a biotechnology company that develops biopharmaceutical.
Viramatix
We develop therapeutics for viral diseases of unmet medical need.
More informations about "Lexicon Therapeutics"
Lexicon Pharmaceuticals - Crunchbase Company …
Nov 26, 2014 Lexicon Pharmaceuticals has established drug discovery alliances with Bristol-Myers Squibb Company, Genentech, Inc., N.V. Organon, and Takeda Pharmaceutical Company Limited. It also has a drug development financing …See details»
Lexicon Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000â„¢ …See details»
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals is a biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic …See details»
Lexicon Pharmaceuticals - Wikipedia
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockoutSee details»
Lexicon Pharmaceuticals, Inc.
As Lexicon continues to evolve, we remain steadfast in our mission to bring new therapeutic solutions to patients in need. Our curiosity propelled us from the Human Genome Project through Genome5000â„¢ to innovate solutions that …See details»
Lexicon Pharmaceuticals - CEO and Investor Conference 2025
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000â„¢ program, Lexicon’s unique genomics target …See details»
Lexicon to Reposition as Clinical Development-Focused Company …
Nov 22, 2024 About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000â„¢ …See details»
Lexicon Pharmaceuticals Provides Business and ... - Markets Insider
Jan 8, 2024 Lexicon continues to focus on accelerating the launch of INPEFA, having recently strengthened and evolved its commercial organization to be better placed for success with …See details»
Lexicon Therapeutics - Crunchbase Company Profile & Funding
Lexicon Therapeutics experienced a significant financial contraction as its stock value decreased, resulting in an 80% loss for investors over three years. Additionally, Lexicon reported renal …See details»
Lexicon Pharmaceuticals Provides Business and Pipeline Update at …
Jan 8, 2024 Lexicon continues to focus on accelerating the launch of INPEFA, having recently strengthened and evolved its commercial organization to be better placed for success with …See details»
Lexicon to Reposition as Clinical Development-Focused
Nov 22, 2024 Through the Genome5000â„¢ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and …See details»
Lexicon Pharmaceuticals Inc - Company Profile - GlobalData
Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. …See details»
Investors | Lexicon Pharmaceuticals, Inc.
Lexicon is the only company to have systematically studied the role and function of thousands of genes, identifying more than 100 precise protein targets. This precision science enables us to …See details»
Lexicon receives CRL for Zynquista - Nasdaq
2 days ago Lexicon (LXRX) Pharmaceuticals announced it has received a complete response letter from the U.S. Food and Drug Administration regarding the New Drug Application for …See details»
Lexicon Pharmaceuticals - Overview, News & Similar companies
Jul 7, 2024 Lexicon Pharmaceuticals has announced that Mike Exton has joined the organization as Chief Executive Officer. ... Lexicon Pharmaceuticals is a biopharmaceutical …See details»
Lexicon Pharmaceuticals - Craft
Oct 29, 2024 Lexicon Pharmaceuticals has 5 employees across 29 locations and $1.2 m in annual revenue in FY 2023. See insights on Lexicon Pharmaceuticals including office …See details»
Lexicon Pharmaceuticals - PitchBook
Dec 13, 2017 Lexicon Pharmaceuticals General Information Description. Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, …See details»
News | Lexicon Pharmaceuticals, Inc.
Nov 20, 2024 Media Inquiries: Corporate Communications [email protected]. Investor Inquiries: Investor Relations [email protected]. Explore Investor Relations See …See details»
Regulatory Roadblock Lexicons Strategic Pivot with Zynquista,
Nov 26, 2024 * Lexicon*s Zynquista Setback: Navigating the Regulatory Maze*In the complex maze of pharmaceutical regulations and approvals, Lexicon Pharmaceuticals recently …See details»
Lexicon Pharmaceuticals, Inc.
Senior Vice President and Chief Medical Officer. Read Bio. Alan Main, PhDSee details»